English  |  Italiano  |  EspañolFrançais
NEW: Free IVF Magazine 2022 - All About IVF - Download Now

IVF+ PGT – patient success stories

Elisa Moya Gutiérrez
Embryologist at UR Vistahermosa, PreGen (UR Vistahermosa)

Category:
Genetics PGS / PGT-A, Success Stories

genetics-pgt-a-success-stories
From this video you will find out:
  • What are the most common genetic disorders? What are the types, symptoms, causes of such disorders?
  • What is PGT-M – Preimplantation Genetic Testing for Monogenic disorder (formerly PGD)?
  • How does PGT-M work, and can it help if the patient is a carrier of Cystic fibrosis, fragile X syndrome, Steinert myotonic dystrophy, etc.?
  • What does PGT-A (referred to as PGS) test for?
  • In which situations is PGT-A recommended?

When should PGT testing be recommended?

In this webinar, Elisa Moya Gutiérrez — Embryologist & Dr Francisco Anaya Blanes — Gynaecologist at PreGen (UR Vistahermosa), Alicante, Spain provided some of their past patients diagnosed with genetic problems. They explained their diagnosis, previous failed attempts, protocols used and treatment offered that helped them to achieve their final goal.

Genetic disorders

A genetic disorder is a disease caused by a change in a DNA sequence. It can be caused by a mutation in one gene, which we call a monogenic disorder, or by a mutation in multiple genes, called multifactorial inheritance disorder. There might also be a combination of gene mutations and environmental factors or damage to the chromosomes, and it would result in changes in the number or the structure of entire chromosomes.

Almost all diseases have a genetic component, some diseases are caused by mutations that are inherited from the parents and are present in the individual at the birth, but other diseases can be caused during the person’s life, such mutations are not inherited from the parent, they occur either randomly or due to some environmental factors.

Monogenic genetic disorders – real-life cases

The first case Elisa presented described an issue with the monogenic disease called Cystic Fibrosis, which is an autosomal recessive disease. It is most common in the Caucasian population, and it is a disease that causes thick, sticky mucous to build up in the lungs, digestive tract and other areas of the body, it is one of the most common types of chronic lung diseases in children and young adults. It’s also a life-threatening disease.

  • a 31-year-old female with low ovarian reserve, Cystic Fibrosis carrier

PGT-M – is one of the genetic studies in embryos that allow detecting genetic alteration or mutations in a specific gene in embryos that would cause a monogenic disease in the offspring. When there is a known reproductive risk, it’s necessary to know the genetic cause of the disease.

The couple came for the first consultation when the female was 31, her mother had early menopause at 39 years old, and the partner was 38 years old with a normal sperm analysis. Before they started the treatment, they decided to do a basic panel of monogenic diseases, and both obtained a result that they were carriers of Cystic Fibrosis, therefore, with this result, the approach of the type of treatment had to be changed. They were recommended to undergo PGT-M.

The female was prescribed 9 days of treatment with antagonists, Bemfola and Meriofert, 7 follicles suitable for puncture were obtained and of which 7 oocytes were obtained, 3 fertilized, and these 3 fertilized oocytes continued to develop up to day 3 of culture with good quality. All 3 embryos were biopsied on day-3, and they have grown until day-5. Two embryos were affected, and 1 was a carrier. The 2 affected embryos were discarded, and the carrier was transferred. The carrier embryo was transferred in a fresh embryo transfer on day-5, and the patient became pregnant.

  • a 33-year-old female was a carrier of Fragile X Syndrome

The next case presented concerned Fragile X Syndrome. This is the most common form of inherited intellectual disability. This disease is caused by a specific gene. Normally, this gene produces an unnecessary protein that is needed for brain development, but a defect in the scene causes a person to make little or no such protein. People who only have a small change in the gene do not have symptoms of Fragile X syndrome, but people with major changes can have severe symptoms, such as intelligence problems, ranging from some learning disabilities to severe intellectual disability, emotional and social problems, speech, and language problems. It is more severe in male patients because fragile X syndrome is caused by annotation in a gene that is located in the X chromosome, and as we know, women have 2X chromosomes, while men have 1X chromosome and 1Y chromosome, so women with the abnormal gene in 1X have another X chromosome with the normal genes. It is less common and less serious when it comes to women. However, when men have this X chromosome with the abnormal gene, they will have more severe symptoms.

In this case, a female patient knew she was a carrier of the Fragile X Syndrome since she had 2 male cousins affected by the syndrome, and she had a normal ovarian reserve. Her 36-year-old husband was a non-carrier of the mutation and had a normal seminogram.

Antagonists protocol was also used, and we obtained 13 oocytes, 11 fertilized, and we obtained 8 embryos which we biopsied on day-5. Two of the biopsied embryos were non-carriers of the disease, so they were suitable for the transfer. We froze them, and when the patient’s and when the endometrium was ready, one of the embryos was transferred, and the patient became pregnant.

  • a 36-year-old affected by Steinert disease with low ovarian reserve

The 3rd case described Steinert Myotonic Dystrophy, which is an autosomal dominant chronic multisystemic hereditary disease with slow progression and high variable heritability, and it can manifest at any time, from birth to older age, in both men and women. This is a muscle disease characterized by myotonia and multi-organ damage that combines varying degrees of muscle weakness, arrhythmias, cardiac conduction disorders, cataracts, endocrine damage or sleep disorders.

The woman was affected with Steinert disease, and she also had a low ovarian reserve, her husband was 42 years old and had a normal sperm analysis. She took antagonists for 8 days, and we obtained 5 oocytes, only 3 of them were in the specific moderation stadium, 2 of them were fertilized, and 2 embryos were biopsied on day-3 of culture, and we also vitrified them on day-5. We obtained 1 suitable embryo, and the other was a carrier of the mutation, so we transferred the healthy embryo, and the patient got pregnant.

Genetic abnormalities – real-life cases

  • a 38-year-old female with normal ovarian reserve and hypothyroidism had 3 miscarriages; a 39-year-old male partner had oligozoospermia & DNA fragmentation

In the case presented, a patient had a normal reserve, but she dealt with 3 miscarriages in the past, she also was under hyperthyroidism treatment. Her 39-year-old husband’s sperms analysis showed oligozoospermia and high DNA fragmentation. She took antagonists for the ovarian stimulation for 11 days, 18 oocytes were obtained, of which 16 were in the specific stage to fertilize, 15 were fertilized with the sperm of the patient, and it was preceded with MACS technique to reduce the DNA sperm fragmentation in the sample. We got 8 embryos that were biopsied on day-5, but none of them was suitable for an embryo transfer because all of them were aneuploid.

The couple decided to try again some months later with the same stimulation, and we obtained 13 oocytes, 11 were fertilized, we biopsied 5 embryos, we obtained 3 suitable embryos, and the rest were aneuploid. We performed a cryotransfer where we transferred 1 embryo, and the patient became pregnant.

The other type of genetic test that is performed is the Pre-Implantation Genetic Test for Aneuploidies (PGT-A), it detects chromosomal alterations in embryos before they’re transferred to the uterus and thus prevents the transmission of serious diseases to offspring and the transfer of embryos that could lead to miscarriage. PGT-A allows discarding those embryos that present a genetic alteration and transferring the ones that have the best quality.

Repeated miscarriages are a pathology that is recognized after the accumulation of 3 or more pregnancies interrupted by spontaneous miscarriages. This type of miscarriage is suffered by 6% of the population, and the percentage of the risk increases when it has already happened on some occasion. The most frequent causes of repeated miscarriages (60%) are because of aneuploid embryos. Although the parents have a normal number of chromosomes, the embryo has the wrong number. This occurs more often in couples where the mother is more than 35 years old.

  • a 41-year-old female with a very low ovarian reserve had 1 cancelled IVF cycle; a 41-year-old male partner with asthenozoospermia & altered FISH result

The FISH analysis is Fluorescence in situ hybridization, and it is done on the sperm samples because when you have an altered FISH result, it means that a percentage of sperm presents chromosomal alteration compared to the percentage of abnormalities that a control population presents. This fact indicated that the individual in question has a higher risk of producing sperm with chromosomal abnormalities and, therefore, embryos carrying aneuploidies. When you have this kind of result, it’s recommended to do an IVF cycle with PGT-A analysis.

The last case presented a couple of 41-year-olds, who had 1 cancelled IVF cycle in another clinic as there was no ovarian response. Therefore, they’ve decided to go ahead with egg donation this time. The male partner had asthenozoospermia and an altered FISH result. We obtained total disomy of sexual chromosomes of 0.9 and an autosomic chromosomes disomy of 0.5. This referred data is out of range with respect to the control population, and the XY disomy rate is increased 3 times over the control value. The diploidy rate is increased to 2.7 times the control value.

From the egg donation, we obtained 21 follicles and 17 oocytes in the specific stadium, 13 fertilized and 7 embryos were biopsied and vitrified. We obtained 3 suitable embryos, and the patient got pregnant in the first cryotransfer.

Conclusions

We have exposed 5 successful cases with complications, they are successful mainly because of seeing the complication of each patient, they all became pregnant on the first or second try, but it’s not always the case. If you look at some data from our clinic (Vistahermosa UR) about the success rates in every treatment. The 90% success rate corresponds to 3 IVF tries that include fresh transfers and cryopreserved transfers. The chances of pregnancy are related to the number of attempts and the personalization of the treatment. They will depend on the age and the number and the quality of the eggs and the sperm sample.

Egg donation is one of the treatments that have the best results, its high percentage of success in 2 cycles is 95%, and this makes it a safe technique that reduces the rate of miscarriages and malformations. This technique is also not influenced by the age of the patient, it’s important that the patient has a normal uterus.

IVF combined with PGT-A allows us to select the embryo with the best implantation possibilities increasing the success rate in the chances of having a healthy baby at home and also reducing the rate of miscarriage and malformations. One IVF cycle with PGT-A would give a 75% of success. Each patient has their own medical history and a number of factors that can lead to infertility. Above all, genetic factors are more complex and highly varied, this is why it’s important to study each case and select the best treatment for each couple, and that’s why we always try to do everything we can to get the best solution.

When should PGT testing be recommended? - Questions and Answers

How can you improve your egg quality? I have had 2 IVF rounds and 3 embryos – blastocysts, but all came back aneuploid after PGT-A testing. I want to improve my results for my 3rd attempt. I am 40.

Some treatments are available to try to improve the egg quality, but unfortunately, they all mostly depend on the patient’s age. At 40, we know that more or less about 60-70% of the embryos are going to be abnormal, so we would advise you to try again. You had 3 embryos, maybe if we had some more blastocysts, we would be able to have 1 healthy embryo to achieve a pregnancy.

We do have some techniques called ovarian rejuvenation, they are still a bit experimental, but in some cases, they can work, and we are doing it with PRP (Platelet Rich Plasma) injection, as I said, it’s a bit experimental, but well it could be something that we will be doing in the future.
There’s no cut off age for this method, but we have to have a minimum ovarian reserve, so if there is established menopause, it’s very difficult to get healthy oocytes, we need to have a minimum ovarian reserve at least.

I am a female nearly 36, I have a balanced translocation with chromosomes 7 and 8. My husband’s karyotype is normal, he’s 36, we had 2 rounds of IVF this year, 35 oocytes, 12 embryos – none came back normal. Is that normal? I don’t want to consider egg donation? Any suggestions to succeed on a third ovarian stimulation? What is the percentage of success in our case (balanced translocation plus 36 years)?

It’s a difficult case to answer, but first I would suggest considering egg donation, maybe not at this moment, but it is something to think about. You could also perform the FISH test because sometimes we think that everything is secondary to the translocation. However, even if your husband’s karyotype is normal, sometimes you can have a normal karyotype and still have failures in the meiosis and the division of the sperm cell, and they can be a carrier of many abnormalities in the sperm cells.

Possibly some of these aneuploid embryos are not only originated by the oocyte but also sperm, you had 12 embryos, and all of them are aneuploid, so possibly it’s like a double transmission, not only from the egg but also from the sperm. If you get aneuploid embryos again before choosing egg donation, make sure to do a FISH test to make sure that you’re going to be successful with the egg donation program.

What is the most common cause of embryo non-evaluation in women under 35?

There are a lot of factors, but I still think that abnormalities in the chromosome are the most common factor, even in women under 35. We see altered embryos in women under 35 as well, it is not only a woman’s factor but also the male factor, which sometimes we tend to forget about. 

Would you recommend testing a frozen embryo for PGT-A, or is it too risky to thaw it for testing?

We would recommend testing it. Nowadays, we prefer to have many frozen embryos. If we have many frozen embryos from a couple, we advise testing them before transferring as we shorten the time to get the clinical pregnancy, we’re not transferring aneuploid embryos. If we have a good number of embryos, even though they are frozen, we test them.

Should we do the FISH test before the 3rd simulation just to have all the chances? What about the MACS test for the sperm? Is it recommended before the 3rd simulation?

think you should do the FISH test before the 3rd try just to know a bit where it comes from. MACS is recommended if the DNA fragmentation of the sperm is high, so you can do a DNA fragmentation test, and if it’s also high, then the MACS technique will be useful.

If you’re going to do PGT-A on the embryos, FISH is not so determinant because we’re going to analyse the embryo, the final product, but if you are thinking of changing gametes, it’s very important to have a FISH test to find out if there are any problems with the sperm.

What does the FISH test mean?

The FISH test is a technique where we see the deployment of the sperm cells, this helps us understand where the aneuploidies come from. If all of your embryos were aneuploid, maybe it comes from the sperm sample. Oocyte and sperm cells are special cells because they go through a special division called meiosis, and they divide the number of chromosomes by half, so this is a crucial and difficult division.

There are many failures in it, FISH test analyses the chromosomes of the sperm cells. Many patients have a normal karyotype, but the FISH test result is abnormal, so it’s important to carry it, we do it more and more every day.

Is PGT-A recommended in embryo adoption?

You can do it, but it’s not recommended because most of the time, the embryos come from donors or women under 35 and men under 40, so in most cases, they are healthy embryos.

Would you recommend to keep going with IVF attempts to find a normal egg if reaching the blastocyst stage at 40 and getting 6 eggs fertilized on both cycles? Would more than 3 cycles be recommended? Can diet improve egg quality?

I would have to study the history a bit more, but you could go on and do one more cycle. However, at some point, you have to change the strategy. You cannot keep going with numerous IVF attempts. Our idea would be to do maybe 1 more attempt, maybe 2, then do a FISH test before going into an egg donation to see if we need to change just the egg or both sperm and the egg. We would need to see what is best for this particular couple.

Having a healthy diet is important, but we don’t think that diet can improve egg quality. We don’t think this is going to change the result.

What is the meiosis study? (I’m reading about it in an article about FISH)?

Meiosis is the division of the sperm and the oocyte cells. It divides the chromosomes by half, that’s why they have half the chromosomes of any other cell to join the sperm with the oocyte and get a healthy baby. That’s why it’s important to do the FISH test on the sperm because in the meiosis many failures occur during this process.

dobule-multi-stimulations
ivf-mindset
implantation-failures-causes
egg-donor-conception-dilemmas
donor-embryo-conception-dilemmas
Authors
Elisa Moya Gutiérrez

Elisa Moya Gutiérrez

Elisa Moya Gutiérrez is one of the embryologists of UR Unidad de Reproducción-Hospital Vistahermosa- Alicante, Spain. She is part of the Andrology and embryology laboratory. Elisa holds a Degree in Biotechnology, by Universidad Europea de Madrid. She is a Master of Science in Reproductive Medicine and Genetics by Universidad Miguel Hernández. Elisa also speaks Spanish, English and German.
Event Moderator
Caroline Kulczycka

Caroline Kulczycka

Caroline Kulczycka is managing MyIVFAnswers.com and has been hosting IVFWEBINARS dedicated to patients struggling with infertility since 2020. She's highly motivated and believes that educating patients so that they can make informed decisions is essential in their IVF journey. In the past, she has been working as an International Patient Coordinator, where she was helping and directing patients on their right path. She also worked in the tourism industry, and dealt with international customers on a daily basis, including working abroad. In her free time, you’ll find her travelling, biking, learning new things, or spending time outdoors.
Free Download
Fertility Road Magazine
A patient-focussed magazine devoted to IVF treatment!
15 articles & 68 pages of "All About IVF"

Disclaimer:

Informations published on myIVFanswers.com are provided for informational purposes only; they are not intended to treat, diagnose or prevent any disease including infertility treatment. Services provided by myIVFanswers.com are not intended to replace a one-on-one relationship with a qualified health care professional and are not intended as medical advice. MyIVFanswers.com recommend discussing IVF treatment options with an infertility specialist.

Contact details: The European Fertility Society C.I.C., 2 Lambseth Street, Eye, England, IP23 7AG
Copyright 2022 MyIVFanswers.com
Donate to the European Fertility Society today!
Your gift will ensure that the European Fertility Society will provide support and education for patients struggling with infertility.
One time donation:
Monthly donation:
Free IVF Magazine 2022.
Download and read articles by top IVF experts worldwide.